Regulatory Conceptsevidence: highv1.0.0
Patient Access Scheme
An arrangement between a pharmaceutical company and NHS England to improve the cost-effectiveness of a medicine.
Definition
Patient Access Schemes (PAS) are commercial arrangements that reduce the effective price of a medicine to the NHS, enabling NICE to recommend technologies that would otherwise exceed the cost-effectiveness threshold. Simple PAS involve a fixed discount. Complex PAS may involve outcomes-based payments, free stock, or capped utilisation.
Canonical Identity
- Authority
- https://www.darrinbaines.org
- Version
- 1.0.0
- Published
- 4/26/2026
- Structured Data
- View JSON-LD →